Grant: Project Grant
McMaster University
$183,600.00
Improving methods for the determination of minimal important difference estimates for patient-reported outcomes and their application in clinical research and decision-making
FY 2019-20
Summary
In deciding whether to use a particular treatment for conditions such as depression, arthritis, or heart disease, doctors and patients must balance the benefits against the side effects and burden. To make this trade-off, they must understand the likely degree of benefit in symptoms and well being. Researchers typically measure symptoms and well-being using questionnaires that ask patients to describe how they are feeling. We call such questionnaires patient-reported outcome measures (PROMs).
More and more, researchers use PROMs to test health care treatments. Information that researchers obtain from PROMs can guide clinical decisions and inform shared-decision making between patients and their doctors. However, the use of PROMs involves challenges. The most important of these challenges is deciding if a particular treatment effect is trivial, small but important, or large. For instance, without further information, patients and clinicians may find it difficult to decide if a 3-point difference on a questionnaire is a trivial or large effect.
One way to make this judgment is to consider the minimal important difference (MID), which represents the smallest change in a PROM score that is important enough that patients would consider a change in treatment to achieve that benefit.
Over the past 3 decades, researchers have developed methods to estimate MIDs for PROMs. However, the studies using these methods are not planned or conducted equally well. Though the MID represents an attractive way of interpreting research results, there is much we are still learning about the methods of measuring MIDs. We plan to lead a series of projects that will further advance MID methods and optimize the presentation and interpretation of results from PROMs in clinical trials, systematic reviews and clinical practice guidelines to inform evidence-based clinical decision-making, ultimately enhancing quality of care and patient outcomes.
Department
Program
Project Grant
Recipient
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
410056
Name
Guyatt Gordon H
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Health Services and Policy Research
Theme2
Clinical
Prcname2
Health Services Evaluation & Interventions Research
Projecttitle
Improving methods for the determination of minimal important difference estimates for patient-reported outcomes and their application in clinical research and decision-making
Programtype2
Operating Grants
Orgnameinp2
McMaster University
Cihramount2
$183,600
Cihrequipment2
$0
Programname2
Project Grant
Keyworddelim
Anchor-Based Methods; Meta-Analysis; Meta-Regression; Minimal Important Differences; Patient Reported Outcomes; Systematic Review
Abstract
In deciding whether to use a particular treatment for conditions such as depression, arthritis, or heart disease, doctors and patients must balance the benefits against the side effects and burden. To make this trade-off, they must understand the likely degree of benefit in symptoms and well being. Researchers typically measure symptoms and well-being using questionnaires that ask patients to describe how they are feeling. We call such questionnaires patient-reported outcome measures (PROMs).
More and more, researchers use PROMs to test health care treatments. Information that researchers obtain from PROMs can guide clinical decisions and inform shared-decision making between patients and their doctors. However, the use of PROMs involves challenges. The most important of these challenges is deciding if a particular treatment effect is trivial, small but important, or large. For instance, without further information, patients and clinicians may find it difficult to decide if a 3-point difference on a questionnaire is a trivial or large effect.
One way to make this judgment is to consider the minimal important difference (MID), which represents the smallest change in a PROM score that is important enough that patients would consider a change in treatment to achieve that benefit.
Over the past 3 decades, researchers have developed methods to estimate MIDs for PROMs. However, the studies using these methods are not planned or conducted equally well. Though the MID represents an attractive way of interpreting research results, there is much we are still learning about the methods of measuring MIDs. We plan to lead a series of projects that will further advance MID methods and optimize the presentation and interpretation of results from PROMs in clinical trials, systematic reviews and clinical practice guidelines to inform evidence-based clinical decision-making, ultimately enhancing quality of care and patient outcomes.
Competitiondate
201909
Approvedterm2
2 yrs 0 mth
Pinamesdelim
Guyatt, Gordon H
Approvedterm
2 ans 0 mois
Cihrcontribution2
~ $183,600~ $0~